Suxibuzone: Difference between revisions
No edit summary |
m (Protected "Suxibuzone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
(No difference)
|
Latest revision as of 17:12, 20 August 2015
WikiDoc Resources for Suxibuzone |
Articles |
---|
Most recent articles on Suxibuzone |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Suxibuzone at Clinical Trials.gov Clinical Trials on Suxibuzone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Suxibuzone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Suxibuzone Discussion groups on Suxibuzone Patient Handouts on Suxibuzone Directions to Hospitals Treating Suxibuzone Risk calculators and risk factors for Suxibuzone
|
Healthcare Provider Resources |
Causes & Risk Factors for Suxibuzone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Suxibuzone is a drug used for joint and muscular pain. It is a prodrug of the non steroidal anti inflammatory drug phenylbutazone, and is commonly used in horses.
References